Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on: December 22,2023

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on:December 22,2023

Research reveals pro-phagocytic function and structural basis of GPR84 signaling

by University of Science and Technology of ChinaGPR84-Gi signaling facilitates cancer cell phagocytosis. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41201-0A recent study,

Updated on: January 28,2024

Research reveals pro-phagocytic function and structural basis of GPR84 signaling

by University of Science and Technology of ChinaGPR84-Gi signaling facilitates cancer cell phagocytosis. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41201-0A recent study,

Updated on:January 28,2024

Old drugs offer new ways of treating bowel cancer

byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found.&quot

Updated on: December 26,2023

Old drugs offer new ways of treating bowel cancer

byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found.&quot

Updated on:December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

Researchers propose a new treatment for brain metastasis based on immunotherapy

byThe Spanish National Cancer Research CentreCells around a brain metastasis in an animal model: several brain cells (astrocytes, white) surround an immune system cell (lymphocyte, green). Some

Updated on: October 24,2024

Researchers propose a new treatment for brain metastasis based on immunotherapy

byThe Spanish National Cancer Research CentreCells around a brain metastasis in an animal model: several brain cells (astrocytes, white) surround an immune system cell (lymphocyte, green). Some

Updated on:October 24,2024

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on: December 20,2023

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on:December 20,2023

Consumer health: What is lung cancer screening, and who needs it?

by Laurel KellyCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. Lung cancer claims more lives each year than co

Updated on: December 18,2023

Consumer health: What is lung cancer screening, and who needs it?

by Laurel KellyCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. Lung cancer claims more lives each year than co

Updated on:December 18,2023

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MDPrithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal tr

Updated on: October 24,2023

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MDPrithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal tr

Updated on:October 24,2023

Survey shows men need to do more to prevent cancer

by Carole Tanzer MillerAmerican men are blowing their best chance to head off cancer or spot it early, when it's easiest to treat, a new survey warns.More than 6 in 10 (65%) men in the nationwide

Updated on: July 06,2024

Survey shows men need to do more to prevent cancer

by Carole Tanzer MillerAmerican men are blowing their best chance to head off cancer or spot it early, when it's easiest to treat, a new survey warns.More than 6 in 10 (65%) men in the nationwide

Updated on:July 06,2024

Scientists develop a peptide that targets lung tumors and delivers therapeutics inside cells

bySRI InternationalMonomeric and tetrameric MGS4 have similar binding, internalization and subcellular location. a, Binding and internalization of tetrameric MGS4_V1 and monomeric MGS4_V2 on liv

Updated on: December 27,2023

Scientists develop a peptide that targets lung tumors and delivers therapeutics inside cells

bySRI InternationalMonomeric and tetrameric MGS4 have similar binding, internalization and subcellular location. a, Binding and internalization of tetrameric MGS4_V1 and monomeric MGS4_V2 on liv

Updated on:December 27,2023

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi

Updated on: December 19,2023

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi

Updated on:December 19,2023

Obesity-cancer connection discovery suggests strategies for improving immunotherapy

by Vanderbilt University Medical CenterImmunofluorescence image shows macrophages (red) in human clear cell renal cell carcinoma, the most common type of kidney cancer in adults. Credit: Jackie B

Updated on: June 15,2024

Obesity-cancer connection discovery suggests strategies for improving immunotherapy

by Vanderbilt University Medical CenterImmunofluorescence image shows macrophages (red) in human clear cell renal cell carcinoma, the most common type of kidney cancer in adults. Credit: Jackie B

Updated on:June 15,2024